№ files_lp_4_process_2_55430
File format: docx
Character count: 1534
File size: 12 KB
Year:
2026
Region / City:
Australia
Theme:
Natural disasters
Document Type:
Report
Organization:
Australian Government
Author:
Unknown
Target Audience:
Public
Action Period:
2026
Approval Date:
2026
Modification Date:
None
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2022
Region / City:
Oriental Mindoro
Topic:
Flooding Incident, Humanitarian Assistance
Document Type:
Terminal Report
Agency / Institution:
Department of Social Welfare and Development (DSWD)
Author:
Marie Joyce G. Rafanan
Target Audience:
Disaster Response Teams, Government Officials, Humanitarian Organizations
Effective Period:
December 2021 – January 2022
Approval Date:
03 January 2022
Date of Changes:
None
Note:
Contextual Description
Year:
2022
Date and Time of Report:
13 January 2022, 6PM
Incident Date:
16 November 2021
Region:
Region IX
Provinces:
Zamboanga del Sur; Zamboanga Sibugay
Hazard Type:
Flooding
Cause of Incident:
Intertropical Convergence Zone (ITCZ)
Affected Population:
11,381 families; 56,727 persons
Affected Barangays:
65
Displaced Population:
1,029 families cumulatively; 457 families currently displaced
Damaged Houses:
1,019 (2 totally damaged; 1,017 partially damaged)
Cost of Assistance Provided:
₱6,196,103.62
Implementing Agency:
Department of Social Welfare and Development (DSWD)
Field Office:
DSWD Field Office IX
Prepared by:
Aaron John B. Pascua
Released by:
Leslie R. Jawili
Source Agencies:
DSWD-DROMIC; DSWD-DRMB; DSWD-NRLMB; DOST-PAGASA
Document Type:
Disaster situation report
Year:
2023
Region / City:
Pass Christian
Topic:
Flood protection
Document Type:
Informational guide
Author:
National Flood Insurance Program (NFIP)
Target Audience:
Homeowners and renters in flood-prone areas
Effective Period:
Ongoing
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2025
Country:
Nepal
Document Type:
Environmental and Social Management Framework
Subject:
Climate change adaptation, Glacial Lake Outburst Floods (GLOFs), flood risk management
Institution:
Government of Nepal, UNDP
Target Audience:
Vulnerable communities, local authorities, national decision-makers
Project Area:
Manang, Sankhuwasabha, Solukhumbu districts
Project Activities:
Risk reduction measures, early warning systems, technical capacity building
Risk Assessment:
Substantial risk (GCF Category B)
Environmental Measures:
Screening, mitigation plans, nature-based solutions
Social Measures:
Gender Action Plan, Indigenous Peoples and marginalized groups inclusion
Funding Source:
Green Climate Fund (GCF)
Implementation Period:
From project approval to completion (specific dates not stated)
Year:
2010
Region / City:
Northern Territory, Australia
Subject:
Statutory Declaration
Document Type:
Form
Authority / Institution:
Nursing and Midwifery Board of Australia
Author:
Not specified
Target Audience:
Applicants for nursing and midwifery registration
Period of Validity:
Not specified
Approval Date:
Not specified
Amendment Date:
Not specified
Year:
2016
Region / City:
Australia
Subject:
Health practitioner regulation, professional misconduct, drug use
Document Type:
Tribunal Decision
Body / Institution:
ACT Civil & Administrative Tribunal
Author:
Medical Board of Australia
Target Audience:
Health professionals, legal professionals
Period of Validity:
N/A
Date of Approval:
8 March 2016
Date of Amendments:
N/A
Year:
2016
Region / City:
Australia
Topic:
Pharmacy, Medicine Compounding
Document Type:
Consultation Response
Organization:
Pharmaceutical Society of Australia
Author:
Dr Lance Emerson, Chief Executive Officer
Target Audience:
Pharmacists, Pharmacy Regulators
Period of Validity:
Indefinite
Approval Date:
1 February 2016
Date of Amendments:
None
Contextual Description:
Document is a public consultation response discussing terminology issues and proposed updates regarding compounded parenteral medicines, primarily aimed at Australian pharmacists.
Year:
2009
Country:
Australia
Jurisdiction:
National
Subject:
Recency of practice requirements in physiotherapy
Document type:
Professional practice guidelines
Issuing body:
Physiotherapy Board of Australia
Legal basis:
Health Practitioner Regulation National Law Act 2009
Target profession:
Physiotherapists
Registration categories covered:
General, specialist, provisional and limited registration
Scope of application:
Registration and renewal of registration
Related standards:
Registration Standard for Recency of Practice
Definitions source:
Australian Standards for Physiotherapy (2006)
Year:
2000-2013
Region / City:
South Australia
Topic:
Epidemiology, Ross River Virus, Public Health
Document Type:
Research Study
Organization / Institution:
South Australian Department for Health and Wellbeing, University of Adelaide
Author:
Jingwen Liu, Alana Hansen, Scott Cameron, Peng Bi
Target Audience:
Public health professionals, researchers, policymakers
Period of Validity:
2000-2013
Approval Date:
Not specified
Date of Last Update:
Not specified
Year:
2023
Region / City:
Australia
Subject:
Chronic migraine, medicinal product submission
Document type:
Submission for PBS listing
Organization:
Novartis Pharmaceuticals Australia Pty. Limited
Author:
Not specified
Target audience:
Health professionals, pharmaceutical regulatory bodies
Period of validity:
Not specified
Date of approval:
2 July 2018
Date of amendments:
November 2023
Year:
2024
Region / City:
Australia
Topic:
Medicinal Product Registration
Document Type:
Submission Report
Agency:
Therapeutic Goods Administration (TGA)
Author:
GlaxoSmithKline Australia
Target Audience:
Medical Practitioners
Treatment Phase:
Initial Treatment
Indication:
Myelofibrosis, including primary, post-polycythaemia vera, and post-essential thrombocythaemia myelofibrosis
Approval Status:
Pending
Date of Submission:
May 2024
Date of Approval:
Not yet approved
Background:
Momelotinib is currently approved in the UK, US, Japan, and the EU.
Description:
Clinical submission for listing momelotinib under the Australian PBS for the treatment of myelofibrosis in patients with moderate to severe anaemia.
Certificate number:
Office use only
Form identifier:
LB1
Document type:
Health certificate
Legislation:
Biosecurity and Agriculture Management Act 2007; Biosecurity and Agriculture Management Regulations 2013
Jurisdiction:
Western Australia
Issuing authority:
Department of Primary Industries and Regional Development
Animal species:
Sheep
Purpose:
Movement of sheep into Western Australia
Consignment scope:
One or more sheep from a property moving to a destination property
Entry inspection points:
Kalgoorlie; Kununurra; Perth Airport; Quarantine facility; Other specified
Parties involved:
Exporting owner or manager; Importing owner or manager; Veterinarian or authorised government inspector
Health conditions covered:
Cattle tick; Footrot; Johne’s disease; Liver fluke
Advance notice requirement:
Copy provided to Entry Inspection Point at least three working days before arrival
Completion requirements:
Parts 1 and 2 completed by specified parties; declarations and signatures required
Source type:
Statutory administrative form establishing health and biosecurity declarations and movement conditions for livestock entering Western Australia.
Year:
2023
Region / city:
Australia
Theme:
Pharmaceutical submission
Document type:
Pharmaceutical submission
Organization / institution:
Pfizer Australia Pty Ltd
Author:
Not specified
Target audience:
Medical practitioners, nurse practitioners
Effective period:
Not specified
Approval date:
Not specified
Amendment date:
Not specified
Context:
Pharmaceutical submission requesting the inclusion of a new formulation of methotrexate under the General Schedule of the PBS for Australia, with changes in packaging and excipient composition.
Year:
2023
Region / city:
Australia
Topic:
Vedolizumab submission for chronic pouchitis treatment
Document type:
Submission for listing of medicinal product
Agency:
Therapeutic Goods Administration (TGA)
Author:
Takeda Pharmaceuticals Australia Pty. Ltd.
Target audience:
Healthcare professionals, regulatory authorities
Effective period:
From 29 June 2023
Approval date:
29 June 2023
Modification date:
N/A
Year:
2022
Region / City:
Australia
Topic:
Medical treatment approval and submission for pembrolizumab and lenvatinib
Document type:
Submission for drug listing
Organization / Institution:
Pharmaceutical Benefits Advisory Committee (PBAC), Therapeutic Goods Administration (TGA)
Author:
Merck Sharp & Dohme (Australia) Pty Ltd
Target audience:
Medical professionals, health regulators
Period of validity:
2022 onward
Approval date:
August 10, 2021
Amendment date:
Not specified
Year:
2024
Region / city:
Australia and New Zealand
Topic:
Refrigerant handling, refrigeration systems, air conditioning
Document type:
Code of Practice
Organ / institution:
AIRAH, Australian Refrigeration Council (ARC), Department of Climate Change, Energy, the Environment and Water (DCCEEW)
Author:
AIRAH, ARC, DCCEEW
Target audience:
Industry professionals, public, refrigeration and air conditioning contractors
Validity period:
Until August 19, 2024
Approval date:
2024
Amendment date:
N/A
Year:
2023
Region / city:
United Kingdom, Australia
Subject:
Preferential Tariff
Document Type:
Regulatory Document
Organization / Institution:
United Kingdom Government
Author:
Not specified
Target Audience:
Customs, Trade Professionals
Period of validity:
From 1st January 2024
Approval Date:
5th December 2023
Date of amendments:
Not specified
Year:
2023
Region / City:
Australia
Theme:
Oncology, Pharmaceutical
Document Type:
Submission
Organization / Institution:
Merck Sharp & Dohme (Australia) Pty Ltd
Author:
Not specified
Target Audience:
Medical professionals, policymakers
Period of Effectiveness:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2018
Region / City:
Australia
Topic:
Pharmaceutical Submission, Cancer Treatment
Document Type:
Submission
Organization / Institution:
Takeda Pharmaceuticals Australia Pty Ltd
Author:
Takeda Pharmaceuticals Australia Pty Ltd
Target Audience:
Healthcare professionals, PBAC
Period of Validity:
Ongoing
Approval Date:
23 May 2018
Date of Amendments:
Not specified